IL258004A - Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapy - Google Patents
Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapyInfo
- Publication number
- IL258004A IL258004A IL258004A IL25800418A IL258004A IL 258004 A IL258004 A IL 258004A IL 258004 A IL258004 A IL 258004A IL 25800418 A IL25800418 A IL 25800418A IL 258004 A IL258004 A IL 258004A
- Authority
- IL
- Israel
- Prior art keywords
- methods
- same
- cancer immunotherapy
- recombinant listeria
- vaccine strains
- Prior art date
Links
- 241000186781 Listeria Species 0.000 title 1
- 238000002619 cancer immunotherapy Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0208—Specific bacteria not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562219961P | 2015-09-17 | 2015-09-17 | |
| PCT/US2016/052322 WO2017049218A2 (en) | 2015-09-17 | 2016-09-16 | Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL258004A true IL258004A (en) | 2018-05-31 |
Family
ID=58289688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL258004A IL258004A (en) | 2015-09-17 | 2018-03-11 | Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapy |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3349789A2 (en) |
| JP (1) | JP2018527382A (en) |
| KR (1) | KR20180043381A (en) |
| CN (1) | CN108348591A (en) |
| AU (1) | AU2016324170A1 (en) |
| CA (1) | CA2998889A1 (en) |
| IL (1) | IL258004A (en) |
| MA (1) | MA42845A (en) |
| MX (1) | MX2018003352A (en) |
| WO (1) | WO2017049218A2 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9012141B2 (en) | 2000-03-27 | 2015-04-21 | Advaxis, Inc. | Compositions and methods comprising KLK3 of FOLH1 antigen |
| EP2683400A4 (en) | 2011-03-11 | 2014-09-17 | Advaxis | ADJUVANTS BASED ON LISTERIA |
| HK1205944A1 (en) | 2012-03-12 | 2015-12-31 | 阿德瓦希斯公司 | Suppressor cell function inhibition following listeria vaccine treatment |
| AU2015219161A1 (en) | 2014-02-18 | 2016-09-29 | Advaxis, Inc. | Biomarker directed multi-target immunotherapy |
| EP3134510B1 (en) | 2014-04-24 | 2023-11-01 | Advaxis, Inc. | Recombinant listeria vaccine strains and methods of producing the same |
| MA41644A (en) | 2015-03-03 | 2018-01-09 | Advaxis Inc | LISTERIA-BASED COMPOSITIONS INCLUDING A MINIGEN EXPRESSION SYSTEM CODING PEPTIDES, AND METHODS OF USE THEREOF |
| SG11201901979SA (en) | 2016-11-30 | 2019-04-29 | Advaxis Inc | Immunogenic compositions targeting recurrent cancer mutations and methods of use thereof |
| JP7284156B2 (en) | 2017-09-19 | 2023-05-30 | アドバクシス, インコーポレイテッド | Compositions and methods for lyophilization of bacteria or Listeria strains |
| CN110499324A (en) * | 2019-09-02 | 2019-11-26 | 中生康元生物科技(北京)有限公司 | A method of for identifying the bacterial expression vector and screening and identification tumour neoantigen of tumour neoantigen |
-
2016
- 2016-09-16 JP JP2018514378A patent/JP2018527382A/en active Pending
- 2016-09-16 WO PCT/US2016/052322 patent/WO2017049218A2/en not_active Ceased
- 2016-09-16 AU AU2016324170A patent/AU2016324170A1/en not_active Abandoned
- 2016-09-16 EP EP16847487.2A patent/EP3349789A2/en not_active Withdrawn
- 2016-09-16 KR KR1020187010508A patent/KR20180043381A/en not_active Withdrawn
- 2016-09-16 CA CA2998889A patent/CA2998889A1/en not_active Abandoned
- 2016-09-16 MA MA042845A patent/MA42845A/en unknown
- 2016-09-16 MX MX2018003352A patent/MX2018003352A/en unknown
- 2016-09-16 CN CN201680066712.0A patent/CN108348591A/en active Pending
-
2018
- 2018-03-11 IL IL258004A patent/IL258004A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3349789A2 (en) | 2018-07-25 |
| CN108348591A (en) | 2018-07-31 |
| MA42845A (en) | 2018-07-25 |
| MX2018003352A (en) | 2018-08-15 |
| CA2998889A1 (en) | 2017-03-23 |
| AU2016324170A1 (en) | 2018-04-12 |
| JP2018527382A (en) | 2018-09-20 |
| KR20180043381A (en) | 2018-04-27 |
| WO2017049218A2 (en) | 2017-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL258563A (en) | Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapy | |
| IL251624A0 (en) | Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapy | |
| IL248483A0 (en) | Recombinant listeria vaccine strains and methods of producing the same | |
| IL258004A (en) | Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapy | |
| SG10202101368WA (en) | Novel peptides and combination of peptides for use in immunotherapy against various cancers | |
| SG10202001485UA (en) | Novel peptides and combination of peptides for use in immunotherapy against various tumors | |
| IL251435A0 (en) | Compositions and methods of use for augmented immune response and cancer therapy | |
| IL247066B (en) | Immunotherapy of cancer through combination of local and systemic immune stimulation | |
| GB201510771D0 (en) | Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer | |
| EP3142496A4 (en) | Direct-fed microbials and methods of their use | |
| EP3215602A4 (en) | Methods and materials for producing recombinant viruses in eukaryotic microalgae | |
| PL3319989T3 (en) | Use of modified fc fragments in immunotherapy | |
| IL249131A0 (en) | Method for decreasing immunogenicity of protein and peptide | |
| IL254129A0 (en) | Novel peptides and combination of peptides for use in immunotherapy against various tumors | |
| GB201416293D0 (en) | Methods and preparations | |
| ZA201604870B (en) | Recombinant microorganisms and methods of use thereof | |
| IL287985A (en) | Koc1-derived peptide and vaccine including same | |
| IL257335A (en) | Depdc1-derived peptide and vaccine containing same | |
| IL250235A0 (en) | Urlc10-derived peptide and vaccine containing same | |
| IL250215A0 (en) | Cdca1-derived peptide and vaccine containing same | |
| HK1237813A1 (en) | Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapy | |
| IL247448A0 (en) | Peptides and methods of use | |
| HK1257010A1 (en) | Fcv recombinant vaccines and uses thereof | |
| AU2015901160A0 (en) | Immunomodulatory peptides and methods of use | |
| HK1226743A1 (en) | Peptides and methods of use |